# K960626: Modular Oncology System Technology (Most)

- Pathway: 510(k) (Traditional)
- Applicant: Intermedics Orthopedics
- Decided: Apr 18, 1996 after 65 days
- Product code: JDI (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented)
- Device class: 2
- Regulation: 21 CFR 888.3350
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
2 later devices descend from it; 1 cites it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) Segmented Oncology System (S.O.S.) Proximal Femur: named in the summary without a submission number
- (no number) MP Reconstruction Prosthesis: named in the summary without a submission number
- (no number) Noiles Total Knee Prosthesis: named in the summary without a submission number
- (no number) Kinematic II Rotating Hinge: named in the summary without a submission number

## Most influential descendants
- K081860: Zimmer Segmental System Variable Stiffness Stem Extensions and Intercalary Segments (2008), 1 descendant of its own
- K192798: Zimmer Segmental System (2020), 0 descendants of its own

## Indications for use
The Modular Oncology System Technology (MOST) will be used for the replacement of the proximal, distal or total femur. Replacement of the distal femur would also include replacement of the proximal tibia and the possible resurfacing of the patella, if necessary. Unlike primary hip and knee systems, this system will be used where the amount of femoral resection and restoration required is extreme (e.g., in oncology cases).

Source page: https://510kreport.com/device/K960626
Methodology: https://510kreport.com/methodology
